Abstract:Background: IL-17 plays a pathogenic role in asthma. ST2(-) inflammatory group 2 innate lymphoid cells (ILC2s) driven by IL-25 can produce IL-17, whereas ST2(+) natural ILC2s produce little IL-17. Objective: We characterized ST2(+) IL-17(+) ILC2s during lung inflammation and determined the pathogenesis and molecular regulation of ST2(+)IL-17(+) ILC2s. Methods: Lung inflammation was induced by papain or IL-33. IL-17 production by lung ILC2s from wild-type, Rag1(-/-), Rorc(gfp/gfp), and aryl hydrocarbon receptor (Ahr)(-/-) mice was examined by using flow cytometry. Bone marrow transfer experiments were performed to evaluate hematopoietic myeloid differentiation primary response gene-88 (MyD88) signaling in regulating IL-17 production by ILC2s. mRNA expression of IL-17 was analyzed in purified naive ILC2s treated with IL-33, leukotrienes, and inhibitors for nuclear factor of activated T cells, p38, c-Jun N-terminal kinase, or nuclear factor kappa light-chain enhancer of activated B cells. The pathogenesis of IL-17(+) ILC2s was determined by transferring wild-type or Il17(-/-) ILC2s to Rag2(-/-) Il2rg(-/-) mice, which further induced lung inflammation. Finally, expression of 106 ILC2 signature genes was compared between ST2(+)IL-17(+) ILC2s and ST2(+)IL-17(-) ILC2s. Results: Papain or IL-33 treatment boosted IL-17 production from ST2(+) ILC2s (referred to by us as ILC2(17)s) but not ST2(-) ILC2s. Ahr, but not retinoic acid receptor-related orphan receptor gamma t, facilitated the production of IL-17 by ILC2(17)s. The hematopoietic compartment of MyD88 signaling is essential for ILC2(17) induction. IL-33 works in synergy with leukotrienes, which signal through nuclear factor of activated T-cell activation to promote IL-17 in ILC2(17)s. Il17(-/-) ILC2s were less pathogenic in lung inflammation. ILC2(17)s concomitantly expressed IL-5 and IL-13 but expressed little GM-CSF. Conclusion: During lung inflammation, IL-33 and leukotrienes synergistically induce ILC2(17)s. ILC2(17)s are a highly pathogenic and unexpected source for IL-17 in lung inflammation.

TGF-β Induces ST2 and Programs ILC2 Development

TGF-beta controls development of TCR gamma delta(+)CD8 alpha alpha(+) intestinal intraepithelial lymphocytes

TGF-β controls development of TCRγδ+CD8αα+ intestinal intraepithelial lymphocytes

ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses

Transcriptional Regulatory Network for the Development of Innate Lymphoid Cells

Suppression of Tumorigenicity 2 (st2) Signaling is Required for Regulatory T Cell Control of Graft-Vs. Host Disease

T Cell Factor 1 Is Required for Group 2 Innate Lymphoid Cell Generation

TGF-|[bgr]|1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4|[plus]|Foxp3|[plus]| regulatory T cells

Differential Role of Id2 in the Group 3 Innate Lymphoid Cells for the Development of Different Gut Associated Lymphoid Tissues

The ETS1 Transcription Factor is Required for the Development and Cytokine-Induced Expansion of ILC2.

Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity

Innate Lymphoid Cells Support Regulatory T Cells in the Intestine Through Interleukin-2.

A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells

Transcriptional regulators dictate innate lymphoid cell fates

A Dynamic Dual Role of IL-2 Signaling in the Two-Step Differentiation Process of Adaptive Regulatory T Cells

ILC2s Induce Adaptive Th2-type Immunity in Different Stages of Tuberculosis Through the Notch-GATA3 Pathway.

The Essential Role Of Single Ig Il-1 Molecule/Toll Il-1r8 In Regulation Immune Response

Dynamic regulation of innate lymphoid cell development during ontogeny

Stage-specific GATA3 induction promotes ILC2 development after lineage commitment

TGF-β Induces Foxp3 + T-Regulatory Cells from CD4 + CD25 − Precursors

IL-17–producing ST2+ Group 2 Innate Lymphoid Cells Play a Pathogenic Role in Lung Inflammation